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Objectives Smoking is associated with adverse 
health outcomes among drug users, including those 
in treatment. To date, however, there has been little 
evidence about smoking patterns among people receiving 
opioid-dependence treatment in developing countries. 
We examined self-reported nicotine dependence and 
associated factors in a large sample of opioid-dependent 
patients receiving methadone maintenance treatment 
(MMT) in northern Vietnam.
Setting Five clinics in Hanoi (urban area) and Nam Dinh 
(rural area).
Participants Patients receiving MMT in the settings 
during the study period.
Primary and secondary outcome measures We 
collected data about smoking patterns, levels of 
nicotine dependence and other covariates such as 
socioeconomic status, health status, alcohol use and 
drug use. The Fagerström test was used to measure 
nicotine dependence (FTND). Logistic regression and 
Tobit regression were employed to examine relationships 
between the smoking rate, nicotine dependence and 
potentially associated variables.
Results Among 1016 drug users undergoing MMT (98.7% 
male), 87.2% were current smokers. The mean FTND 
score was 4.5 (SD 2.4). Longer duration of MMT (OR 0.98, 
95% CI 0.96 to 0.99) and being HIV-positive (OR 0.46, 95% 
CI 0.24 to 0.88) were associated with lower likelihood of 
smoking. Being employed, older age at first drug injection 
and having long duration of MMT were inversely related 
with FTND scores. Higher age and continuing drug and 
alcohol use were significantly associated with higher FTND 
scores.
Conclusion Smoking prevalence is high among 
methadone maintenance drug users. Enhanced smoking 
cessation support should be integrated into MMT 
programmes in order to reduce risk factors for cigarette 
smoking and improve the health and well-being of people 
recovering from opiate dependence.
InTroducTIon
Despite the reduction of smoking worldwide, 
cigarette smoking rates remain high among 
opiate-dependent individuals—three or four 
times higher than in the general popula-
tion.1–4 A systematic review of Guydish et al 
in 2011 indicated that smoking rates among 
patients in addiction treatment ranged from 
65% to 87.2%.5 Smoking is a primary cause 
of morbidity and mortality in illicit drug 
users.6 7 Evidence indicates that the death 
rates of smokers who had received opioid 
abuse treatment were four times greater 
than that of their counterparts.8 Addition-
ally, smokers with a range of other substance 
abuse problems were more likely to die due 
to smoking-related illnesses compared with 
their non-smoking peers.6 8
Methadone maintenance treatment (MMT) 
is an effective method to reduce opiate use 
and improve health status.9 10 However, some 
evidence suggests that short-term MMT may 
increase smoking in a dose-dependent rela-
tionship, with higher dose of MMT associated 
with greater nicotine dependence.11–13 Nico-
tine appears to make methadone or other 
opiates more efficaciously reinforced14; 
therefore, MMT patients may be more likely 
to continue to smoke, and to smoke heavily, 
Strengths and limitations of this study
 ► The study included a large sample in multiple clinics 
in urban and rural areas.
 ► The study employed validated instruments to 
increase the comparability of the study.
 ► The causal relationships could not be established 
due to the cross-sectional design.
 ► All data were gathered by retrospective self-report 
without biochemical confirmation, which might may 
mask under-reporting of ongoing drug use.
 ► The convenience sampling strategy limited the 
generalisability of findings.
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when taking MMT to counteract the sedating effects of 
methadone or to produce a more pleasurable experience 
when tobacco and methadone are used together.1 15
In contrast, a study by Helena et al found that people 
with a long duration of MMT were likely to change their 
smoking habits, reducing nicotine dependence and ciga-
rette smoking.16 In addition, some prior research suggests 
a high level of motivation to quit smoking among long-
term MMT patients.17 However, other research indicates 
that there is no significant association between ongoing 
MMT and smoking levels or quitting attempts.18
Globally, Vietnam is one of the countries with very high 
prevalence of tobacco smoking. Approximately 23.8% 
of adults smoke, and there is a major gender difference, 
with 47.4% of men and 1.4% of women being current 
cigarette smokers.19 Smoking is a major contributor to 
disease burden in Vietnam, accounting for 6.2% of total 
deaths.20 Health surveys of people with opioid depen-
dence have described sexual activities,21 concurrent drug 
use,22 23 quality of life21 and health service utilisation,24 
but there has been little analysis of smoking behaviour in 
this population in Vietnam. This study explored the prev-
alence of smoking and levels of nicotine dependence, 
and associated factors among MMT patients. Our study 
is among the first to provide evidence on the pattern of 
smoking cigarettes during opioid-dependence treatment 
in Vietnam. The purpose was to contribute evidence to 
support implementation of dedicated smoking cessation 
services for opiate users in treatment in Vietnam.
MaTerIals and MeThods
survey design and sampling
We conducted a cross-sectional study from June to August 
2013 at five clinics in Hanoi and Nam Dinh. These two 
provinces have a high prevalence of HIV-positive patients 
in the northern region of Vietnam, with 19 987 and 3577 
people living with HIV/AIDS, respectively.25 Sampling 
was undertaken at clinics at central, provincial and 
district levels that had at least 150 MMT patients. The 
characteristics of the study sites are shown in table 1.
Participant recruitments
Participants were eligible if they (1) received daily metha-
done, (2) were aged ≥18 years and (3) agreed to provide 
written informed consent. Patients were excluded if 
they had any health or communication problems that 
prevented them from answering the questionnaire.
Eligible patients were invited when they visited the 
clinics. If they agreed to enrol, they were asked to give 
written informed consent. A private room in each clinic 
was arranged to ensure confidentiality and to create a 
comfortable atmosphere during the interview. A sample 
of 1016 patients was enrolled in the study, accounting for 
90% of MMT patients in five clinics.
Data collectors did not engage in the provision of 
care or treatment. No direct healthcare providers were 
involved in the interview or handling of data. Interviewers 




The primary outcome was current smoking status, cate-
gorised into two groups: current smoker (yes/no). 
Participants were classified as a current cigarette smoker 
if they have ever smoked at least 100 cigarettes in their 
life and have smoked in the last 30 days. Those who have 
never smoked 100 cigarettes and not currently smoking 
or participants who have smoked 100 cigarettes but have 
been abstinent in the last 30 days were categorised as 
non-smokers.26 Among current smokers, nicotine depen-
dence was measured by the Fagerström test for nicotine 
dependence (FTND).27 28 The FTND instrument has been 
applied elsewhere in Vietnam.29 The total scores range 
from 0 to 10. The higher the Fagerström score indicates 
the greater nicotine dependence. Regarding FTND score, 
patients were categorised into five groups: 0–2, very low; 
3–4, low; 5, moderate; 6–7, high; and 8–10, very high.
Study covariates
Socio-demographic variables consisted of sex, age, 
monthly income, employment status, educational 
attainment, residential area and marital status. Monthly 
household income included all sources of income for each 
household member and was collected via self-reported 
information by patients. Based on income information, 
patients were classified into five quintile groups: poorest, 
poor, middle, rich and richest.
Health status was self-reported by employing the five-
level EQ-5D (EQ-5D-5L) instrument.30 This includes five 
Table 1 Study settings and sample size
Level Settings Site name Type of services
Sample 
size
District (urban) Nam Dinh City Provincial AIDS Centre MMT + VCT 270
District (rural) Xuan Truong District District Health Centre MMT + VCT + ART + GH 151
District (urban) Tu Liem District District Health Centre MMT + VCT + ART + GH 201
District (urban) Long Bien District District Health Centre MMT + VCT + ART + GH 184
District (urban) Ha Dong District Regional Polyclinic MMT+ GH 210
ART, antiretroviral therapy; GH, general healthcare; MMT, methadone maintenance treatment; VCT, voluntary counselling and testing.
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dimensions (mobility, self-care, usual activities, pain/
discomfort and anxiety/depression). The EQ-5D-5L has 
been validated in Vietnamese context.31 Respondents 
who experienced from ‘slightly’ to ‘extremely’ on an item 
were categorised as ‘currently having pain or anxiety’. 
Those who reported no pain or anxiety were categorised 
as ‘no pain/anxiety’. Other health conditions examined 
included HIV infection status and whether they received 
antiretroviral treatment (ART).
Alcohol use was assessed using the Alcohol Use Disor-
ders Identification Test—Consumption (AUDIT-C), a 
brief version of the 10-question AUDIT instrument.32 33 
The AUDIT-C score ranges from 0 to 12, where ≥4 in men 
and ≥3 in women are considered at-risk drinking.34 The 
higher score means the greater alcohol dependence. The 
AUDIT-C instrument has been validated for Vietnamese 
populations elsewhere.35 36
Drug use characteristics were assessed regarding history 
of drug use, age at onset of drug use and drug injection 
and number of episodes of drug rehabilitation.35 Partici-
pants who reported using any substance (heroin, cocaine, 
methamphetamine) at least once within the past month 
were considered concurrent drug users during MMT. 
Duration of MMT was assessed by self-reported.
statistical analysis
Data were analysed using Stata V.12.0 for Windows. t-Tests, 
Mann-Whitney tests and χ2 tests were applied to identify 
differences among socio-demographic, drug and alco-
hol-related and health-related characteristics by current 
smoking status (yes/no).
Multivariate logistic regression, combined with polyno-
mial fractions for the duration of MMT treatment, was 
employed to determine factors associated with being a 
current smoker. Additionally, this model controlled for 
nesting of participants within each of the five clinic sites. 
Variables associated with the outcome in bivariate anal-
ysis with a p<0.25 were included in the multivariate model 
manually in a forward stepwise manner. Only statistically 
significant variables with a p<0.05 were retained in the 
final model.
Because the FTND score was censored from 0 to 10, 
we used Tobit regression to examine the relationships 
between FTND scores and potentially related factors.37 We 
also used a stepwise backward strategy, which is based on 
the log-likelihood ratio test. The threshold of p value<0.1 
was used to include variables. All potential interactions 
were examined. The Hosmer-Lemeshow goodness-of-fit 
test was employed to assess model calibration. A p value 
<0.05 was considered statistically significant.
resulTs
Table 2 indicates the characteristics of respondents. Most 
participants were men (98.7%) compared with just 1.3% of 
women, and they mainly came from urban areas (85.15). 
The mean age was 36.8 years (SD 7.6). Most respon-
dents had less than a high school education (55.3%). 
The majority were married or lived with their partners 
(67.7%). One-fifth of respondents were employed. The 
average monthly income was 5.2 million VND, approxi-
mately US$250 (SD 4.2).
One-third of participants were hazardous drinkers 
(29.6%). Patients with a history of heroin injection 
accounted for >70% of the sample. Only 5 in 100 patients 
reported current illicit drug use during treatment 
(4.8%). The average length of MMT was 16.5 months 
(SD 11.0). Overall, 17.7% and 20.7% of participants 
reported currently feeling pain and/or anxiety, respec-
tively. Respondents with mobility and self-care problem 
were 7.3% and 3.9%, respectively. Half of the participants 
were enrolled in MMT clinics that had comprehensive 
packages (including MMT, HIV testing and counselling 
services, ART and general healthcare (GH)).
Table 2 shows that the proportion of MMT patients who 
currently smoked was 87.3% of men and 76.9% of women. 
The difference between male and female smokers was not 
statistically significant (p=0.26), probably because of the 
very small number of females in this study. Smoking status 
was significantly different between groups regarding age, 
history of drug injection, age at initiation of drug use and 
MMT clinic models (p<0.05).
Smoking behaviour and nicotine dependence among 
MMT patients are revealed in table 3. Mean age of initial 
smoking was 17.2 years (SD 3.5), with mean duration 
of regular smoking being 14.1 years (SD 8.5). A total 
of 306,300 VND per month were spent for cigarettes 
(= US$15). Among smokers, mean FTND score was 4.5 
(SD 2.4), and most of them were in low (27.0%) and very 
low dependence (26.1%) groups.
Figure 1 indicates that the smoking rate and FTND 
score were high in the early phase of treatment, and then 
significantly decreased afterwards.
The reduced multivariate model in table 4 shows that 
patients with high school education (OR 2.29, 95% CI 
1.28 to 4.07) were more likely to report current smoking 
than others. Being HIV-positive (OR 0.46, 95% CI 0.24 
to 0.88) was negatively associated with current smoking. 
Individuals having longer duration of MMT were less 
likely to smoke than others (OR 0.98; 95% CI 0.96 to 
0.99).
Table 4 shows the findings from the Tobit model. Being 
employed, higher age at first drug injection and having 
long duration of MMT treatment were inverse factors 
for FTND scores. Further, higher age and having other 
single or multiple substance abuse (illicit drug, alcohol 
drinking) were significantly associated with higher FTND 
score.
dIscussIon
The smoking rate among MMT patients was very high, 
with 87.3% of men and 79.6% of women being current 
smokers. Smoking prevalence among the mostly male 
MMT clients was twice the national average for men (about 
47%) in the general population.19 This is consistent with 
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research in other countries, such as Switzerland, the USA, 
Australia, Canada, Mexico and England.8 38–42 The high 
persistence of smoking might be explained by the 
interactive effects of addictive substances such as meth-
adone, narcotics and nicotine.14 Consequently, patients 
during MMT may be more vulnerable to smoking than 





N (%) 130 (12.8) 886 (87.2) 1016 (100)
Socio-demographics
  Age in years, mean years (SD) 38.6 (8.3) 36.5 (7.5) 36.8 (7.6) <0.01
  Gender, n (%)
  Female 3 (23.1%) 10 (76.9%) 13 (1.3) 0.26
  Male 127 (12.7%) 876 (87.3%) 1003 (98.7)
  Monthly income (million VND), mean (SD) 4.8 (3.8) 5.2 (4.2) 5.2 (4.2) 0.29
  Marital status (n, %)
Single/divorced/separated/widowed 35 (10.7) 293 (89.3) 328 (32.3) 0.16
Live with spouse/partner 95 (13.8) 593 (86.2) 688 (67.7)
  Education (n, %)
Less than high school 80 (14.2) 482 (85.8) 562 (55.3) 0.18
High school 40 (10.3) 347 (89.7) 387 (38.2)
More than high school 10 (14.9) 57 (85.1) 67 (6.5)
  Location (n, %)
Urban 104 (12) 761 (88) 865 (85.1) 0.08
Rural 26 (17.2) 125 (82.8) 151 (14.9)
  Employment status (n, %)
Unemployed 39 (14.9) 222 (85.1) 261 (25.5) 0.46
Self-employed 64 (11.8) 478 (88.2) 542 (53.4)
Employed 27 (12.7) 186 (87.3) 213 (21.1)
Substance use, n (%)
  Hazardous drinking (n, %) 35 (11.6) 266 (88.4) 301 (29.6) 0.88
  History of drug injection (n, %) 81 (10.9) 665 (89.1) 746 (73.4) <0.01
  Current drug use (n, %) 4 (8.2) 45 (91.8) 49 (4.8) 0.32
  Age of drug use, mean age (SD) 25.7 (7.8) 24.4 (6.6) 24.5 (6.7) 0.04
  Age of drug injection, mean age (SD) 26.8 (8.2) 26.8 (7.2) 26.8 (7.3) 0.97
  Number of drug rehabilitation, mean episode (SD) 5.3 (7.8) 4.8 (6.0) 4.8 (6.3) 0.98
  MMT duration, mean months (SD) 18.0 (12.1) 16.3 (10.8) 16.5 (11.0) 0.20
Health-related characteristics
  Current ART, n (%) 13 (19.7) 53 (80.3) 66 (6.5) 0.08
  Currently feeling pain, n (%) 24 (13.3) 156 (86.7) 180 (17.7) 0.81
  Currently feeling anxiety, n (%) 28 (13.3) 182 (86.7) 210 (20.7) 0.60
  Currently perceive mobility problem, n (%) 8 (10.8) 66 (89.2) 74 (7.3) 0.79
  Currently perceive self-care problem, n (%) 7 (17.5) 33 (82.5) 40 (3.9) 0.36
  Currently perceive usual activity problem, n (%) 7 (11.7) 53 (88.3) 60 (5.9) 0.79
MMT service delivery model
  MMT + VCT 32 (11.9) 238 (88.1) 270 (26.6) 0.03
  MMT + GH 17 (8.1) 193 (91.9) 210 (20.7)
  MMT + VCT + ART + GH 81 (15.1) 455 (84.9) 536 (52.8)
ART, antiretroviral therapy; GH, general healthcare; MMT, methadone maintenance treatment; VCT, voluntary counselling and testing.
group.bmj.com on September 6, 2017 - Published by http://bmjopen.bmj.com/Downloaded from 
 5Do HP, et al. BMJ Open 2017;7:e015889. doi:10.1136/bmjopen-2017-015889
Open Access
in general populations. Some evidence indicates that 
smoking helps drug users to cope with cravings.43 44 
Additionally, methadone use might contribute to high 
consumption of cigarettes because MMT patients smoke 
to counteract the sedating effects of methadone. It is also 
possible that there are pleasing effects when cigarettes 
and methadone are taken together.1 15 Together, these 
effects might be a barrier for smoking cessation among 
MMT patients. To date, in Vietnam, only two official 
smoking cessation clinics for opiate users in treatment, 
one in Hanoi and one in Ho Chi Minh City, have been in 
operation. Therefore, plans to scale up MMT nationally 
should consider integrating smoking cessation services to 
diminish the smoking epidemic in this population.
The current study shows that longer duration of MMT 
was associated with lower likelihood of current smoking 
and less nicotine dependence. Notably, smoking increased 
gradually in the first 30 months (but not significantly) 
and decreased remarkably afterwards. It is possible that 
in the initial stage of treatment smoking helped patients 
to counter the aftertaste of MMT and may have enhanced 
the pleasing effects.45 Consequently, they may have 
been more likely to smoke cigarettes until they could 
feel comfortable with the side effects of MMT. A study 
by Abbott46 with 189 MMT patients found that after 12 
months of treatment smoking support cessation was the 
fourth most requested and important service although 
very few patients requested this service at baseline.46
Likewise, we observed higher FTND scores among 
patients in the first five months of MMT and then a steady 
decrease afterwards. It may be that in the first few months 
patients would require a high dose for effective treat-
ment, which leads to more severe nicotine dependence 
(as indicated by the FTND score).13 47 In contrast, patients 
treated with MMT for a long time tend to receive stable 
or lower methadone doses, which may diminish nicotine 
dependence and promote the intention to quit smoking.3 
The evidence from Vietnam is consistent with a study in 
Slovakia by Okruhlica et al, which suggested that the level 
of nicotine dependence was reduced after 12 months of 
treatment when the MMT dose was stabilised.48
Respondents with multiple substance abuse (alcohol 
and illicit drug use) had higher nicotine dependence, 
especially among those who concurrently used illicit 
drugs during MMT. The complex relationships between 
smoking, alcohol and drug use have been well-doc-
umented in global settings. People having one risk 
behaviour (such as drug use) tend to engage in other 
behaviours (such as smoking and alcohol).45 49–52 There-
fore, these relationships during the course of MMT are 
clinically important that should be carefully monitored 
and controlled, which could help to identify who may 
need to receive specific cessation interventions at MMT 
sites.
This study also found significant associations between 
smoking and socio-demographic factors such as age, 
education and employment. Older age was correlated with 
higher nicotine dependence (higher FTND score). This 
is consistent with studies in Korea and China.53 54 Addi-
tionally, people with high school education were more 
Table 3 Smoking pattern of Vietnamese methadone 
maintenance treatment patients
Characteristic N (%)
Age at smoking initiation, mean years (SD) 17.2 (3.5)
Duration of regular smoking, mean years 
(SD)
14.1 (8.5)
Expense for smoking (1,000 VND per 
month), mean (SD)
306.3 (289.4)
Fagerström test for nicotine dependence 
score, mean (SD)
4.5 (2.4)
Nicotine dependence scale, n (%)
 Very low 231 (26.1)
 Low 239 (27.0)
 Moderate 115 (12.9)
 High 184 (20.8)
 Very high 117 (13.2)
Number of cigarette per day, n (%)
 ≤10 409 (46.2)
 11–20 407 (45.9)
 21–30 49 (5.5)
 >30 21 (2.4)
Figure 1 Smoking pattern of methadone maintenance treatment (MMT) patients regarding the duration of MMT: (A) prevalence 
of cigarette smoker; (B) Fagerström test for nicotine dependence (FTND) score.
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likely to smoke compared with those with lower educa-
tion. This is somewhat counterintuitive given the inverse 
relationship between education and smoking in many 
countries,30 but could be explained by an associated 
factor such as income. It might be anticipated that the 
highly educated respondents are more likely to have 
higher income to spend more on tobacco consumption.
Results of multivariable regression indicated that 
HIV-positive drug users were less likely to be current 
smokers, which could be related to perceptions about 
health risks. Fears about impending poor physical health 
due to HIV/AIDS could encourage patients to avoid risky 
behaviours such as smoking and alcohol use.55 However, 
empirical evidence worldwide suggests that people under-
taking both ART and MMT often relapse and smoke 
more often.29 56 Furthermore, when they believe that they 
will not live long enough to suffer from smoking-related 
illnesses, or perceive that they are at a lower health risk 
for continued smoking especially during a stable stage of 
ART, they may smoke more.55 Therefore, special atten-
tion should be paid to MMT patients living with HIV in 
order to help them avoid risk behaviours and promote a 
healthier lifestyle.
This study has strengths that included a large sample 
size (1016 MMT patients) and high response rate, collab-
oration with multiple clinics in various areas and validated 
instruments (eg, FTND, AUDIT-C, EQ-5D-5L). None-
theless, several limitations should be considered. First, 
the causal relationships could not be established due 
to the cross-sectional design. Additionally, all data were 
gathered via retrospective self-report interviews without 
biochemical confirmation. This may have resulted in 
under-reporting of ongoing drug use due and introduce 
recall and disclosure bias. Finally, due to the convenience 
sampling strategy at clinics in just two geographical areas, 
the generalisation of our results is limited.
conclusIon
This study revealed that smoking is highly prevalent 
among MMT patients, putting them at a high risk of smok-
ing-related illnesses. Despite the decrease of smoking over 
Table 4 Factors associated with smoking status
Characteristics
Current smoking (yes/no) FTND score
OR 95% CI Coefficient 95% CI
Age 0.04* 0.01 0.08
Education (vs < high school)
  High school 2.29* 1.28 4.07
Occupations (vs unemployed)
  Employed −0.55* −1.07 −0.03
Income quintile (vs poorest)
  Rich 0.52† −0.03 1.07
  Richest 0.63† 0.10 1.17
HIV status (vs negative)
  Positive 0.46* 0.24 0.88 −0.44 −1.11 0.22
  Unknown −0.76 −1.76 0.24
Age of first drug injection −0.07* −0.11 −0.02
Substance use
Interaction between current drug use and alcohol 
drinking (vs no use drug + no drink hazardously)
  Only drink hazardously 1.51 0.82 2.78 0.83* 0.37 1.30
  Only use drug 1.61* 0.23 3.25
  Both use drug + drink hazardously 1.75* 0.24 3.25
No. of drug rehabilitation (vs none)
  1–5 times −0.33 −0.75 0.09
Duration of MMT (months) 0.98* 0.96 0.99 −0.03* −0.05 −0.01
MMT delivery model (vs MMT + VCT)
  MMT + GH 2.11* 0.98 4.56
  MMT + VCT + ART + GH −0.30 −0.73 0.13
*p<0.05; †p<0.1.
ART, antiretroviral therapy; FTND, Fagerström test for nicotine dependence; GH, general healthcare; MMT, methadone maintenance 
treatment; VCT, voluntary counselling and testing.
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the course of MMT, smoking cessation support should be 
integrated into MMT programmes in Vietnam in order to 
diminish smoking-related adverse outcomes.
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